Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 2581 AL 2595

A case of McLeod phenotype of neuroacanthocytosis brain MR features and literature review

Shah JR, Patkar DP, Kamat RN.

Neuroradiol J. 2013 Feb;26(1):21-6. doi: 10.1177/197140091302600103. Epub 2013 Mar 8.

Alterations in the frequency of trinucleotide repeat dynamic mutations in offspring conceived through assisted reproductive technology

Zheng YM, Li L, Zhou LM, Le F, Cai LY, Yu P, Zhu YR, Liu XZ, Wang LY, Li LJ, Lou YY, Xu XR, Lou HY, Zhu XM, Sheng JZ, Huang HF, Jin F.

Hum Reprod. 2013 Sep;28(9):2570-80. doi: 10.1093/humrep/det294. Epub 2013 Jul 16.

Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions

Murray D, Stoessl AJ.

Pharmacol Ther. 2013 Dec;140(3):306-18. doi: 10.1016/j.pharmthera.2013.07.009. Epub 2013 Jul 21.

Head drop in Huntington disease: insights into the pathophysiology

Morgante F, Girlanda P, Martino D.

Neurology. 2013 Aug 20;81(8):769-70. doi: 10.1212/WNL.0b013e3182a1aa55. Epub 2013 Jul 24.

The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease

Noch EK, Khalili K.

Adv Cancer Res. 2013;120:159-92. doi: 10.1016/B978-0-12-401676-7.00006-1.

Protein aggregation in bacteria: the thin boundary between functionality and toxicity

Bednarska NG, Schymkowitz J, Rousseau F, Van Eldere J.

Microbiology (Reading). 2013 Sep;159(Pt 9):1795-1806. doi: 10.1099/mic.0.069575-0. Epub 2013 Jul 26.

Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype

Borroni B, Cotelli MS, Marchina E, Filosto M, Premi E, Padovani A.

Clin Neurol Neurosurg. 2013 Oct;115(10):2217-8. doi: 10.1016/j.clineuro.2013.06.020. Epub 2013 Jul 27.

Organotypic cultures as tools for optimizing central nervous system cell therapies

Daviaud N, Garbayo E, Schiller PC, Perez-Pinzon M, Montero-Menei CN.

Exp Neurol. 2013 Oct;248:429-40. doi: 10.1016/j.expneurol.2013.07.012. Epub 2013 Jul 27.

Mithramycin, an agent for developing new therapeutic drugs for neurodegenerative diseases

Osada N, Kosuge Y, Ishige K, Ito Y.

J Pharmacol Sci. 2013;122(4):251-6. doi: 10.1254/jphs.13r02cp. Epub 2013 Jul 30.

NKX2-1 mutation in a family diagnosed with ataxic dyskinetic cerebral palsy

McMichael G, Haan E, Gardner A, Yap TY, Thompson S, Ouvrier R, Dale RC, Gecz J, Maclennan AH.

Eur J Med Genet. 2013 Sep;56(9):506-9. doi: 10.1016/j.ejmg.2013.07.003. Epub 2013 Jul 30.

A systematic review of the intergenerational aspects and the diverse genetic profiles of Huntington's disease

Agostinho LA, Dos Santos SR, Alvarenga RM, Paiva CL.

Genet Mol Res. 2013 Jun 13;12(2):1974-81. doi: 10.4238/2013.June.13.6.

The first case report of McLeod syndrome in a Chinese patient

Man BL, Yuen YP, Yip SF, Ng SH.

BMJ Case Rep. 2013 Aug 13;2013:bcr2013200205. doi: 10.1136/bcr-2013-200205.

De novo Huntington disease caused by 26-44 CAG repeat expansion on a low-risk haplotype

Houge G, Bruland O, Bjørnevoll I, Hayden MR, Semaka A.

Neurology. 2013 Sep 17;81(12):1099-100. doi: 10.1212/WNL.0b013e3182a4a4af. Epub 2013 Aug 14.

Defining the role of the Bcl-2 family proteins in Huntington's disease

Sassone J, Maraschi A, Sassone F, Silani V, Ciammola A.

Cell Death Dis. 2013 Aug 15;4(8):e772. doi: 10.1038/cddis.2013.300.

Epigenetic modifications in trinucleotide repeat diseases

Evans-Galea MV, Hannan AJ, Carrodus N, Delatycki MB, Saffery R.

Trends Mol Med. 2013 Nov;19(11):655-63. doi: 10.1016/j.molmed.2013.07.007. Epub 2013 Aug 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias